Posted On: 01/22/2016 2:12:10 PM
Post# of 72447
Re: NotRichYet2 #17763
Market cap 156.42 Million, 4 clinical trials in progress, 3 Orphan Drug designations, 1 QIDP designation.
AXON: market cap 1.7 Billion, yes with a B, one clinical trial gearing up for a drug that already failed a previous clinical trial.
Which one would you rather own?
AXON: market cap 1.7 Billion, yes with a B, one clinical trial gearing up for a drug that already failed a previous clinical trial.
Which one would you rather own?
(0)
(0)
